Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Fishtech Labs invests $3M in Overland Park security firm
Tech accelerator Fishtech Labs on Thursday announced its first major investment in Foresite, an Overland Park-based managed security provider. Founded by serial entrepreneur Gary Fish, the Kansas City-based accelerator is investing $3 million in Foresite, which offers cyber security and compliance services for businesses. Unlike most managed service providers, Foresite uses a “white label” approach…
Digital divide initiative could help 9,000 Kansas City households
More than 9,000 Kansas City households are among the potential beneficiaries of a new national digital divide initiative. Comcast recently partnered with the U.S. Department of Housing and Urban Development’s ConnectHome initiative, marking the largest expansion to Comcast’s Internet Essentials program. Now all Kansas City households within a Comcast service area that receive HUD housing…
New Startland reporter wants to immerse herself in KC’s culture of innovation
Two months ago today, I packed up the last of my belongings in my Columbia, Mo. apartment. And to be frank, I was slightly embarrassed to be moving back in with my parents in Independence, Mo. A recent graduate from the University of Missouri’s School of Journalism, it seemed that almost everybody I knew was…
Exclusive: John Fein departing Techstars to lead new $7M Midwest venture fund
After three years with the Kansas City-based Sprint Accelerator, John Fein is moving on to lead a venture fund that has ambitious Midwestern plans. Fein, who’s served as the managing director at the Techstars-led accelerator since 2014, will serve his last day with the organization on July 31. With decades of fast-paced startup experience, Fein…